Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2026 23:29 ET | Source: NeuroSalt

NeuroSalt Under Investigation: What the 2026 Formulation Transparency Review Reveals About Botanical Ingredients, Dosage Disclosure, and Consumer Verification

What a 2026 ingredient review of NeuroSalt's botanical nerve formula found — and the consumer verification questions most coverage skips.
April 10, 2026 22:53 ET | Source: Pulsetto

Pulsetto Claims Evaluated: 2026 Update on the Pulsetto Vagus Nerve Stimulator, Features, Pricing, and Consumer Use Considerations

Pulsetto vagus nerve stimulator 2026 update covering Lite vs FIT, pricing context, FCC certification, and consumer wellness use considerations.
April 10, 2026 21:13 ET | Source: Emma

Emma Relief Claims Evaluated: Rising Consumer Interest in Gut Health Formulas for Bloating and Digestive Support in 2026

Ingredient context, consumer considerations, and 2026 category positioning for Emma Relief, the daily gut health formula from Enclave BioActives.
April 10, 2026 19:41 ET | Source: Gentle Patches

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

Gentle Patches draws rising 2026 consumer interest as the pill-free transdermal wellness patch lineup highlights ingredient and policy details.
April 10, 2026 18:54 ET | Source: IVY Rx

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

IVY Rx releases 2026 compounded GLP-1 telehealth program information covering pricing tiers, clinician access, and pharmacy fulfillment details.
April 10, 2026 18:45 ET | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit– Hagens Berman

Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 10, 2026 17:13 ET | Source: ReadyRx

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

ReadyRx's 2026 update details prescription NAD+ nasal spray and injection access, compounded therapy structure, pricing, and clinician eligibility.
April 10, 2026 17:02 ET | Source: Replimune, Inc.

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
April 10, 2026 16:09 ET | Source: Mesoblast Limited

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are living with DMD in the U.S. NEW YORK, April 10,...
April 10, 2026 14:27 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors

LOS ANGELES, April 10, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Atara Biotherapeutics, Inc., (“Atara” or the "Company") (NASDAQ: ATRA) investors of a class action on behalf of investors...
April 10, 2026 14:06 ET | Source: Robbins LLP

Robbins LLP Reminds CORT Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact Robbins LLP for Information About Leading the Class Action

Robbins LLP is Investigating Allegations that Corcept Therapeutics Incorporated (CORT) Misled Investors Regarding the Viability of its New Product Candidat
April 10, 2026 13:56 ET | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: Corcept Therapeutics (CORT) Investors with Substantial Losses Have Opportunity to Lead the Corcept Class Action Lawsuit– Hagens Berman

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 10, 2026 13:53 ET | Source: Hagens Berman Sobol Shapiro LLP

INVESTOR DEADLINE: uniQure (QURE) Investors with Substantial Losses Have Opportunity to Lead the uniQure Class Action Lawsuit– Hagens Berman

Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 10, 2026 13:30 ET | Source: Law Offices of Howard G. Smith

DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., April 10, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
April 10, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Corcept (CORT) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 4/21/2026
April 10, 2026 11:50 ET | Source: The Gross Law Firm

QURE Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in uniQure N.V. Securities Class Action Lawsuit — The Gross Law Firm

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of uniQure N.V. (NASDAQ: QURE). Shareholders who purchased shares of QURE during the...
April 10, 2026 11:47 ET | Source: The Gross Law Firm

RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit — The Gross Law Firm

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of REGENXBIO Inc. (NASDAQ: RGNX). Shareholders who purchased shares of RGNX during the...
April 10, 2026 11:44 ET | Source: The Gross Law Firm

AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Aquestive Therapeutics, Inc. (NASDAQ: AQST). Shareholders who purchased shares of AQST...
April 10, 2026 11:41 ET | Source: The Gross Law Firm

CORT Shareholder Alert: Corcept Therapeutics Incorporated Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). Shareholders who purchased shares of...
April 10, 2026 11:29 ET | Source: The Gross Law Firm

ATRA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Atara Biotherapeutics, Inc. Securities Lawsuit — The Gross Law Firm

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Atara Biotherapeutics, Inc. (NASDAQ: ATRA). Shareholders who purchased shares of ATRA...
April 10, 2026 11:11 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Atara Biotherapeutics, Inc. Investors They Have Until May 22nd to Seek Lead Plaintiff Role in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Atara (ATRA) To Contact Him Directly To Discuss Their Options If you purchased or...
April 10, 2026 11:01 ET | Source: Research and Markets

Personalized Skin Care Products Market Analysis and Forecast 2026-2035: AI-Driven Transformation Fuels USD 72.23 Billion Market by 2035

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Personalized Skin Care Products Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ...
April 10, 2026 11:01 ET | Source: Bragar Eagel & Squire

UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In uniQure (QURE) To Contact Him Directly To Discuss Their Options If you purchased or...
April 10, 2026 10:22 ET | Source: Schall Law

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 10, 2026 08:30 ET | Source: Annovis Bio Inc.

Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission

Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75% enrolledParkinson's disease open-label study 28%...
April 10, 2026 08:15 ET | Source: LifeMD, Inc.

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo™ (orforglipron) to...
April 10, 2026 08:00 ET | Source: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT

MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of...
April 10, 2026 07:00 ET | Source: NeurAxis, Inc.

NeurAxis, Inc. Announces Preferred Stock Dividend

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for...
April 10, 2026 06:59 ET | Source: Opus Genetics, Inc.

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
April 10, 2026 06:38 ET | Source: Research and Markets

1 Day Understanding Key Factors When Working with the FDA Training Course: Streamlining Drug Application Processes, Specifically for NDAs, Generics, and Biosimilars (ONLINE EVENT: May 12, 2026)

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "US FDA - Understanding Key Factors When Working with the FDA (May 12, 2026)" training has been added to ResearchAndMarkets.com's offering.This course...
April 10, 2026 05:21 ET | Source: Research and Markets

New EU GMP Annex 1 Guidance Course for Compliant Sterile Medicinal Products (ONLINE EVENT: May 19th - May 23rd, 2026)

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "New EU GMP Annex 1: Compliant Sterile Medicinal Products (May 19th - May 23rd, 2026)" training has been added to ResearchAndMarkets.com's...
April 10, 2026 05:15 ET | Source: Research and Markets

1 DAY ONLINE COURSE: Navigating US and EU Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests (May 15, 2026)

Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The "Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests (May 15, 2026)" training has been...
April 09, 2026 20:32 ET | Source: Leanzene

Best ACV Gummies Claims Evaluated: What Ingredient Labels Actually Disclose vs. What Marketing Pages Emphasize — 2026 Consumer Transparency Update

ACV gummy label analysis: what ingredient panels disclose, where research-supported dosages diverge from proprietary blends, and what to check
April 09, 2026 19:59 ET | Source: Vita Smart Cup Massager

Vita Smart Cup Massager Claims Evaluated: 2026 Report on Suction Therapy, Red Light Technology, and What Consumers Should Know Before Buying

Vita Smart Cup Massager claims examined. 2026 report covers suction, red light, and heat features, undisclosed specs, pricing, and return terms.
April 09, 2026 19:26 ET | Source: Hagens Berman Sobol Shapiro LLP

Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate– Hagens Berman

Investors who lost money in AARD after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
April 09, 2026 18:51 ET | Source: Telix Pharmaceuticals Limited

FDA Accepts NDA for TLX101-Px (Pixclara®)

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug...
April 09, 2026 17:10 ET | Source: The Rosen Law Firm PA

CORT FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Corcept Therapeutics Incorporated (NASDAQ: CORT) between...
April 09, 2026 17:10 ET | Source: The Rosen Law Firm PA

מועד אחרון להגשת תביעה ייצוגית נגד CORT: רוזן, משרד עורכי דין מוכר מאוד, מעודד משקיעים ב-Corcept Therapeutics Incorporated עם הפסדים של יותר מ-100,000 דולר לקבל ייעוץ משפטי לפני המועד החשוב ב-21 באפריל בתביעה ייצוגית בניירות ערך – CORT

ניו יורק, April 10, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את המניות הרגילות של Corcept Therapeutics...
April 09, 2026 16:05 ET | Source: Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

WEST CHESTER, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of...
April 09, 2026 16:01 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth

Board member and Interim CEO Mani Mohindru, PhD, named President and Chief Executive OfficerAppoints industry veterans Josh Muntner as Chief Financial Officer and Ajay Aggarwal, MD, MBA, as Chief...
April 09, 2026 14:58 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING NATIONAL FIRM, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) between May 20,...
April 09, 2026 13:36 ET | Source: The Rosen Law Firm PA

מועד אחרון לתביעה הייצוגית נגד QURE: רוזן, משרד עורכי דין מוביל, מעודד משקיעים ב-uniQure N.V עם הפסדים העולים על 100,000 דולר לקבל ייעוץ משפטי לפני המועד החשוב ב-13 באפריל בתביעה ייצוגית בניירות ערך – QURE

ניו יורק, April 09, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את המניות הרגילות של uniQure N.V. (נאסד"ק:...
April 09, 2026 13:36 ET | Source: The Rosen Law Firm PA

QURE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025...
April 09, 2026 13:29 ET | Source: Law Offices of Howard G. Smith

DEADLINE ALERT for ATRA, COTY, SMCI, IBRX: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
April 09, 2026 13:27 ET | Source: Glancy Prongay Wolke & Rotter LLP

Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, April 09, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the class action...
April 09, 2026 13:00 ET | Source: DelveInsight Business Research LLP

Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight

New York, USA, April 09, 2026 (GLOBE NEWSWIRE) -- Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight The...
April 09, 2026 12:12 ET | Source: SkyMedia, LLC

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

NEW ORLEANS, April 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 21, 2026 to file lead plaintiff applications in a...
April 09, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Atara (ATRA) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/22/2026.
April 09, 2026 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for uniQure N.V. (QURE) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 4/13/2026.
April 09, 2026 11:54 ET | Source: SkyMedia, LLC

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

NEW ORLEANS, April 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 13, 2026 to file lead plaintiff applications in a...